Abstract
Using a previously developed spectrophotometric method (Bioorg. Khim. 2009, vol. 35, pp. 629–639) a significant increase of myeloperoxidase (MPO) activity (versus healthy control) was found in blood plasma of patients with type 2 diabetes mellitus (DM2) without cardiovascular complications, and also in patients with ischemic heart disease (IHD). The plasma MPO concentration measured by an enzyme-linked immunosorbent assay was significantly higher only in blood plasma of patients with DM2 and IHD. A significant positive correlation between blood MPO activity and blood MPO content was observed only in blood plasma samples from healthy donors. Increased MPO activity did not correlate with MPO concentration in blood plasma of patients with DM2 and DM2 with IHD. Taken together, these results indicate that studies on the MPO role in the development of pathological processes should include simultaneous determination of both the amount of enzyme and its peroxidase activity in blood of patients. The proposed approach gives comprehensive information about the relationship between MPO activity and MPO concentration in patient’s blood. Since the high concentration of MPO is a diagnostically important parameter for the prediction of development of endothelial dysfunction and cardiovascular diseases, the obtained results point to the contribution of MPO-dependent reactions in cardiovascular complications associated with diabetes mellitus. MPO activity may serve as an additional diagnostic criterion for determination of risk of IHD in DM patients.
Similar content being viewed by others
Abbreviations
- DM2:
-
type 2 diabetes mellitus
- ELISA:
-
enzyme-linked immunosorbent assay
- fMLP:
-
N-formyl-Met-Leu-Phe
- IHD:
-
ischemic heart disease
- LDL:
-
low density lipoproteins
- MPO:
-
myeloperoxidase
References
Zhang, C., Yang, J., and Jennings, L.K., Diabetes, 2004, vol. 53, pp. 2950–2959.
Jacobi, J., Sela, S., Cohen, H.I., Chezar, J., and Kristal, B., Am. J. Physiol. Heart Circ. Physiol., 2006, vol. 290, pp. H2051–H2058.
Shurtz-Swirski, R., Sela, S., Herskovits, A.T., Shasha, S.M., Shapiro, G., Nasser, L., and Kristal, B., Diabetes Care, 2001, vol. 24, pp. 104–110.
Stegenga, M.E., van der Crabben, S.N., Blümer, R.M.E., Levi, M., Meijers, J.C.M., Serlie, M.J., Tanck, M.W.T., Sauerwein, H.P., and van der Poll, T., Blood, 2008, vol. 112, pp. 82–89.
Podrez, E.A., Abu-Soud, H.M., Hazen, S.L., Free Radic. Biol. Med., 2000, vol. 28, pp. 1717–1725.
Lau, D. and Baldus, S., Pharmacol. Ther., 2006, vol. 111, pp. 16–26.
Nicholls, S.J. and Hazen, S.L., J. Lipid Res., 2009, vol. 50, pp. 346–351.
Daugherty, A., Dunn, J.L., Rateri, D.L., and Heinecke, J.W., J. Clin. Invest., 1994, vol. 94, pp. 437–444.
Stenvinkel, P., Rodríguez-Ayala, E., Massy, Z.A., Qureshi, A.R., Barany, P., Fellström, B., Heimburger, O., Lindholm, B., and Alvestrand, A., Clin. J. Am. Soc. Nephrol., 2006, vol. 1, pp. 281–287.
Boker, T., Augustin, A.J., Breipohl, W., Spitznas, M., and Lutz, J., Graefes Arch. Clin. Exp. Ophthalmol., 1994, vol. 232, pp. 652–656.
Uchimura, K., Nagasaka, A., Hayashi, R., Makino, M., Nagata, M., Kakizawa, H., Kobayashi, T., Fujiwara, K., Kato, T., Iwase, K., Shinohara, R., Kato, K., and Itoh, M., J. Diabetes Complications, 1999, vol. 13, pp. 264–270.
Heilman, K., Zilmer, M., Zilmer, K., Lintrop, M., Kampus, P., Kals, J., and Tillmann, V., Diabetes Res. Clin. Pract., 2009, vol. 84, pp. 168–173.
Schindhelm, R.K., Alssema, M., Diamant, M., Teerlink, T., Dekker, J.M., Kok, A., Kostense, P.J., Nijpels, G., Heine, R.J., and Scheffer, P.G., Metabolism, 2008, vol. 57, pp. 262–267.
Gorudko, I.V., Cherkalina, O.S., Sokolov, A.V., Pulina, M.O., Zakharova, E.T., Vasilyev, V.B., Cherenkevich, S.N., and Panasenko, O.M., Bioorg. Khim., 2009, vol. 35, no. 5, pp. 1–11.
Sokolov, A.V., Ageeva, K.V., Pulina, M.O., Cherkalina, O.S., Samygina, V.R., Vlasova, I.I., Panasenko, O.M., Zakharova, E.T., and Vasilyev, V.B., Free Rad. Res., 2008, vol. 42, pp. 989–998.
Gorudko, I.V., Timoshenko, A.V., Timoshenko, A.P., Vacker, A.V., Timoshenko, P.A., and Cherenkevich, S.N., Central East Eur. J. Oto-Rhino-Laryngol. Head Neck Surg., 1997, vol. 2, pp. 22–27.
Timoshenko, A.V., Kayser, K., and Gabius, H.J., Meth. Mol. Med., 1998, vol. 9, pp. 441–445.
Elgawish, A., Glomb, M., Friedlander, M., and Monnier, V.M., J. Biol. Chem., 1996, vol. 272, pp. 12964–12971.
Moreno-Navarrete, J.M., Ortega, F.J., Bassols, J., Ricart, W., and Fernández-Real, J.M., J. Clin. Endocrinol. Metab., 2009, vol. 94, pp. 4036–4044.
Gewirtz, A.T., Fokin, V.V., Petasis, N.A., Serhan, C.N., and Madara, J.L., Am. J. Physiol. Cell Physiol., 1999, vol. 276, pp. C988–C994.
Bajaj, M.S., Kew, R.R., Webster, R.O., and Hyers, T.M., Inflammation, 1992, vol. 16, pp. 241–250.
Singh, U., Devaraj, S., and Jialal, I., Clin. Chem., 2009, vol. 55, pp. 361–364.
Gorudko, I.V., Vakhrusheva, T.V., Mukhortova, A.V., Cherenkevich, S.N., Timoshenko, A.V., Sergienko, V.I., and Panasenko, O.M., Biol. Membr., 2010, vol. 27, pp. 314–324.
Vlasova, I.I., Arnhold, J., Osipov, A.N., and Panasenko, O.M., Biochemistry (Moscow), 2006, vol. 71, pp. 825–837.
Hawkins, C.L. and Davies, M.J., Chem. Res. Toxicol., 2005, vol. 18, pp. 1600–1610.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.V. Gorudko, V.A. Kostevich, A.V. Sokolov, I.V. Buko, E.E. Konstantinova, N.L. Tsapaeva, E.V. Mironova, E.T. Zakharova, V.B. Vasilyev, S.N. Cherenkevich, O.M. Panasenko, 2011, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Gorudko, I.V., Kostevich, V.A., Sokolov, A.V. et al. Increased myeloperoxidase activity is a risk factor for ischemic heart disease in patients with diabetes mellitus. Biochem. Moscow Suppl. Ser. B 5, 307–312 (2011). https://doi.org/10.1134/S199075081103005X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S199075081103005X